J Allergy Clin Immunol Pract.
50. Werfel T, Allam JP, Biedermann T, et al. Cellular and molecular
immunologic mechanisms in patients with atopic dermatitis. J
Allergy Clin Immunol. 2016;138(2):336-349.
51. Brunner PM, Guttman-Yassky E, Leung DY. The immunology of atopic
dermatitis and its reversibility with broad-spectrum and targeted
therapies. J Allergy Clin Immunol. 2017;139(4s):S65-s76.
52. Noda S, Suárez-Fariñas M, Ungar B, et al. The Asian atopic
dermatitis phenotype combines features of atopic dermatitis and
psoriasis with increased TH17 polarization. J Allergy Clin
Immunol. 2015;136(5):1254-1264.
53. Czarnowicki T, Esaki H, Gonzalez J, et al. Early pediatric atopic
dermatitis shows only a cutaneous lymphocyte antigen (CLA)(+) TH2/TH1
cell imbalance, whereas adults acquire CLA(+) TH22/TC22 cell subsets.J Allergy Clin Immunol. 2015;136(4):941-951.e943.
54. Czarnowicki T, Gonzalez J, Shemer A, et al. Severe atopic dermatitis
is characterized by selective expansion of circulating TH2/TC2 and
TH22/TC22, but not TH17/TC17, cells within the skin-homing T-cell
population. J Allergy Clin Immunol. 2015;136(1):104-115.e107.
55. Biedermann T, Röcken M, Carballido JM. TH1 and TH2 lymphocyte
development and regulation of TH cell-mediated immune responses of the
skin. J Investig Dermatol Symp Proc. 2004;9(1):5-14.
56. Biedermann T, Skabytska Y, Kaesler S, Volz T. Regulation of T cell
immunity in atopic dermatitis by microbes: The yin and yang of cutaneous
inflammation. Front Immunol. 2015;6(353).
57. Ivert LU, Wahlgren CF, Lindelöf B, Dal H, Bradley M, Johansson EK.
Association between atopic dermatitis and autoimmune diseases: a
population-based case-control study. Br J Dermatol. 2020.
58. Firestein GS, McInnes IB. Immunopathogenesis of rheumatoid
arthritis. Immunity. 2017;46(2):183-196.
59. Rork JF, Rashighi M, Harris JE. Understanding autoimmunity of
vitiligo and alopecia areata. Curr Opin Pediatr.2016;28(4):463-469.
60. Paternoster L, Standl M, Waage J, et al. Multi-ancestry genome-wide
association study of 21,000 cases and 95,000 controls identifies new
risk loci for atopic dermatitis. Nat Genet.2015;47(12):1449-1456.
61. Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on
rhinosinusitis and nasal polyps 2020. Rhinology. 2020;58(Suppl
S29):1-464.
62. Haselkorn T, Chen H, Miller DP, et al. Asthma control and activity
limitations: insights from the Real-world Evaluation of Asthma Control
and Treatment (REACT) study. Ann Allergy Asthma Immunol.2010;104(6):471-477.
63. Kijima A, Murota H, Takahashi
A, et al. Prevalence and impact of past history of food allergy in
atopic dermatitis. Allergol Int. 2013;62(1):105-112.
64. Heck S, Al-Shobash S, Rapp D,
et al. High probability of comorbidities in bronchial asthma in Germany.NPJ Prim Care Respir Med. 2017;27(1):28.
65. Kämpe M, Vosough M,
Malinovschi A, et al. Upper airway and skin symptoms in allergic and
non-allergic asthma: Results from the Swedish GA(2)LEN study. J
Asthma. 2018;55(3):275-283.
66. Lee LK, Obi E, Paknis B, Kavati A, Chipps B. Asthma control and
disease burden in patients with asthma and allergic comorbidities.J Asthma. 2018;55(2):208-219.
67. Matsusaka M, Kabata H, Fukunaga K, et al. Phenotype of asthma
related with high serum periostin levels. Allergol Int.2015;64(2):175-180.
68. Pinart M, Benet M,
Annesi-Maesano I, et al. Comorbidity of eczema, rhinitis, and asthma in
IgE-sensitised and non-IgE-sensitised children in MeDALL: a
population-based cohort study. Lancet Respir Med.2014;2(2):131-140.
69. Christiansen ES, Kjaer HF,
Eller E, et al. The prevalence of atopic diseases and the patterns of
sensitization in adolescence. Pediatr Allergy Immunol.2016;27(8):847-853.
70. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its
Impact on Asthma (ARIA) 2008 update (in collaboration with the World
Health Organization, GA(2)LEN and AllerGen). Allergy.2008;63(Suppl 86):8-160.
71. Licari A, Brambilla I, De Filippo M, Poddighe D, Castagnoli R,
Marseglia GL. The role of upper airway pathology as a co-morbidity in
severe asthma. Exp Rev Respir Med. 2017;11(11):855-865.
72. Tay TR, Radhakrishna N,
Hore-Lacy F, et al. Comorbidities in difficult asthma are independent
risk factors for frequent exacerbations, poor control and diminished
quality of life. Respirology. 2016;21(8):1384-1390.
73. Castillo Vizuete JA, Sastre J,
Del Cuvillo Bernal A, et al. Asthma, rhinitis, and nasal polyp
multimorbidities. Arch Bronconeumol. 2019;55(3):146-155.
74. Asano T, Kanemitsu Y, Takemura
M, et al. Serum periostin as a biomarker for comorbid chronic
rhinosinusitis in patients with asthma. Ann Am Thorac Soc.2017;14(5):667-675.
75. Marseglia GL, Merli P, Caimmi
D, et al. Nasal disease and asthma. Int J Immunopathol Pharmacol.2011;24(4 Suppl):7-12.
76. Heffler E, Blasi F, Latorre M,
et al. The Severe Asthma Network in Italy: Findings and perspectives.J Allergy Clin Immunol Pract. 2019;7(5):1462-1468.
77. Schleich F, Brusselle G, Louis
R, et al. Heterogeneity of phenotypes in severe asthmatics. The Belgian
Severe Asthma Registry (BSAR). Respir Med.2014;108(12):1723-1732.
78. Tran MM, Lefebvre DL, Dharma C, et al. Predicting the atopic march:
Results from the Canadian Healthy Infant Longitudinal Development Study.J Allergy Clin Immunol. 2018;141(2):601-607.e608.
79. Silverberg JI. Selected
comorbidities of atopic dermatitis: Atopy, neuropsychiatric, and
musculoskeletal disorders. Clin Dermatol. 2017;35(4):360-366.
80. Čelakovská J, Ettlerová K,
Ettler K, Vaněčková J, Bukač J. Sensitization to aeroallergens in atopic
dermatitis patients: association with concomitant allergic diseases.J Eur Acad Dermatol Venereol. 2015;29(8):1500-1505.
81. Werner-Busse A, Kostev K,
Heine G, Worm M. Impact of comorbidities on the treatment of atopic
dermatitis in clinical practice. Int J Clin Pharmacol Ther.2014;52(9):726-731.
82. Silverberg JI. Comorbidities and the impact of atopic dermatitis.Ann Allergy Asthma Immunol. 2019;123(2):144-151.
83. Jyonouchi S, Brown-Whitehorn
TA, Spergel JM. Association of eosinophilic gastrointestinal disorders
with other atopic disorders. Immunol Allergy Clin North Am.2009;29(1):85-97.
84. Ravnborg N, Ambikaibalan D, Agnihotri G, et al. Prevalence of asthma
in patients with atopic dermatitis: a systematic review and
meta-analysis. J Am Acad Dermatol. 2020; doi:
10.1016/j.jaad.2020.02.055.
85. Chandra RK, Lin D, Tan B, et al. Chronic rhinosinusitis in the
setting of other chronic inflammatory diseases. Am J Otolaryngol.2011;32(5):388-391.
86. Blauvelt A, de Bruin-Weller M,
Gooderham M, et al. Long-term management of moderate-to-severe atopic
dermatitis with dupilumab and concomitant topical corticosteroids
(LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded,
placebo-controlled, phase 3 trial. Lancet.2017;389(10086):2287-2303.
87. Shrestha S, Miao R, Wang L, Chao J, Yuce H, Wei W. Burden of atopic
dermatitis in the United States: analysis of healthcare claims data in
the commercial, Medicare, and Medi-Cal databases. Adv Ther.2017;34(8):1989-2006.
88. Sicras-Mainar A, Navarro-Artieda R, Carrascosa Carrillo JM. Economic
impact of atopic dermatitis in adults: A population-based study (IDEA
Study). Actas Dermosifiliogr. 2018;109(1):35-46.
89. Halling AS, van Hauen M, Eggers-Lura VH, Knudgaard MH, Loft N,
Thyssen JP. Association between atopic dermatitis and nasal polyposis:
what is the evidence? J Eur Acad Dermatol Venereol.2021;35(4):e290-e293.
90. Licari A, Castagnoli R, Denicolò CF, Rossini L, Marseglia A,
Marseglia GL. The nose and the lung: United airway disease? Front
Pediatr. 2017;5:44.
91. Boulet LP, Boulay M. Asthma-related comorbidities. Exp Rev
Respir Med. 2011;5(3):377-393.
92. Gelardi M, Iannuzzi L, Tafuri
S, Passalacqua G, Quaranta N. Allergic and non-allergic rhinitis:
relationship with nasal polyposis, asthma and family history. Acta
Otorhinolaryngol Ital. 2014;34(1):36-41.
93. Gilaberte Y, Pérez-Gilaberte JB, Poblador-Plou B, Bliek-Bueno K,
Gimeno-Miguel A, Prados-Torres A. Prevalence and comorbidity of atopic
dermatitis in children: A large-scale population study based on
real-world data. J Clin Med. 2020;9(6):E1632.
94. Huang Y, Zhang Y, Zhang L. Prevalence of allergic and nonallergic
rhinitis in a rural area of northern China based on sensitization to
specific aeroallergens. Allergy Asthma Clin Immunol. 2018;14:77.
95. Bachert C, Hellings P, Mullol J. Atopic comorbidities and biomarkers
of type 2 inflammation in patients with chronic rhinosinusitis with
nasal polyposis (CRSwNP) who failed intranasal corticosteroids. Poster
presentation at: 2018 AAAAI/WAO Joint Congress; March 2-5, 2018;
Orlando, FL. Abstract 288. 2018.
96. Vernon N, Shah S, Lehman E, Ghaffari G. Comparison of atopic
features between children and adults with eosinophilic esophagitis.Allergy Asthma Proc. 2014;35(5):409-414.
97. Straumann A, Aceves SS, Blanchard C, et al. Pediatric and adult
eosinophilic esophagitis: similarities and differences. Allergy.2012;67(4):477-490.
98. Williamson P, Aceves S.
Allergies and eosinophilic esophagitis - Current updates for the
pediatric gastroenterologist. Curr Gastroenterol Rep.2019;21(11):56.
99. Durrani SR, Mukkada VA, Guilbert TW. Eosinophilic esophagitis: An
important comorbid condition of asthma? Clin Rev Allergy Immunol.2018;55(1):56-64.
100. Mohammad AA, Wu SZ, Ibrahim O, et al. Prevalence of atopic
comorbidities in eosinophilic esophagitis: A case-control study of 449
patients. J Am Acad Dermatol. 2017;76(3):559-560.
101. Penfield JD, Lang DM, Goldblum JR, Lopez R, Falk GW. The role of
allergy evaluation in adults with eosinophilic esophagitis. J Clin
Gastroenterol. 2010;44(1):22-27.
102. Welsh L, Lercher P, Horak E.
Exhaled nitric oxide: interactions between asthma, hayfever, and atopic
dermatitis in school children. Pediatr Pulmonol.2007;42(8):693-698.
103. Hill DA, Grundmeier RW, Ramos
M, Spergel JM. Eosinophilic esophagitis is a late manifestation of the
allergic march. J Allergy Clin Immunol Pract.2018;6(5):1528-1533.
104. Erkman J, Vaynblat A, Thomas K, et al. Airway and esophageal
eosinophils in children with severe uncontrolled asthma. Pediatr
Pulmonol. 2018;53(12):1598-1603.
105. Kapoor R, Menon C, Hoffstad O, Bilker W, Leclerc P, Margolis DJ.
The prevalence of atopic triad in children with physician-confirmed
atopic dermatitis. J Am Acad Dermatol. 2008;58(1):68-73.
106. van der Hulst AE, Klip H, Brand PL. Risk of developing asthma in
young children with atopic eczema: a systematic review. J Allergy
Clin Immunol. 2007;120(3):565-569.
107. Thorsteinsdottir S, Stokholm J, Thyssen JP, et al. Genetic,
clinical, and environmental factors associated with persistent atopic
dermatitis in childhood. JAMA Dermatol. 2019;155(1):50-57.
108. Ricci G, Patrizi A, Baldi E, Menna G, Tabanelli M, Masi M.
Long-term follow-up of atopic dermatitis: retrospective analysis of
related risk factors and association with concomitant allergic diseases.J Am Acad Dermatol. 2006;55(5):765-771.
109. Chehade M, Jones SM, Pesek RD, et al. Phenotypic characterization
of eosinophilic esophagitis in a large multicenter patient population
from the Consortium for Food Allergy Research. J Allergy Clin
Immunol Pract. 2018;6(5):1534-1544.e1535.
110. Capucilli P, Cianferoni A, Grundmeier RW, Spergel JM. Comparison of
comorbid diagnoses in children with and without eosinophilic esophagitis
in a large population. Ann Allergy Asthma Immunol.2018;121(6):711-716.